ProgressSara Attanà2025-01-21T14:11:15+01:00

Progress

WP1 | Project management, risk assessment and ethical issues 50%

WP2 | Specifications, requirements and benchmarking 50%

WP3 | Multifunctional biomaterials and REBORN technologies 100%

WP4 | Conventional and advanced in vitro test 80%

WP5 | TRL 5 translation and demonstration 20%

WP6 | Pre-clinical validation 0%

WP7 | Clinical specifications, regulatory aspects and cost assessment 0%

WP8 | Business cases development, exploitation and dissemination 50%

PROJECT DETAILS

PROJECT NUMBER: 101091852
PROJECT TITLE: Remodelling of the infarcted heart: piezoelectric multifunctional patch enabling the sequential release of therapeutic factors
TOPIC: HORIZON-CL4-2022-RESILIENCE-01-13
START DATE: 01 January 2023
DURATION: 48 Months
GRANTING AUTHORITY: European Health and Digital Executive Agency
EU CONTRIBUTION: € 4.050.412,50 Euro

“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do notnecessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.”